Federal Injury Centers

Item 7 lays out the entry barriers clearly: initial investment spans $94,300 to $195,000, kicked off by a $49,000 franchise fee, covering branding, ops manuals, billing systems, and supplies for either direct clinics or management services. Ongoing fees bite hard at 8.5% royalties plus a 6.5% billing fee (capping at 9.5%), alongside $380 monthly for the business management system and up to $500 for tech. System health shines in Item 20's growth trajectory—55 franchise units in 2023 jumped 15% to 63 in 2024, with 4 projected new units—indicating robust demand in this underserved federal injury market, though no Item 19 means prospective buyers must infer profitability from closures, transfers, and renewals rather than hard revenue stats.

Litigation in Item 3 flags risks: disputes over unauthorized operations, unjust enrichment, trademark issues, and a messy franchisee termination involving breach, covenants, and franchise law counterclaims. Without Item 19 disclosure, evaluating ROI hinges on validating OWCP claim volumes and reimbursement rates through validation calls or third-party data. This model's specialized billing edge could yield high margins in a recession-resistant federal sector, but the fee stack and legal noise demand rigorous due diligence on unit-level economics before committing.